102 results on '"Bradley, Linda"'
Search Results
2. Comparing endometrial biopsy results with hysteroscopic pathology in women presenting with abnormal and postmenopausal uterine bleeding
3. The Impact of Fertility Goals on Long-term Quality of Life in Reproductive-aged Women Who Underwent Myomectomy versus Hysterectomy for Uterine Fibroids
4. Diagnostic Considerations and Surgical Techniques for a Large Prolapsing Submucosal Myoma
5. PSGL-1 attenuates early TCR signaling to suppress CD8+ T cell progenitor differentiation and elicit terminal CD8+ T cell exhaustion
6. Refugees’ aspirations, attitudes, and experiences of higher education and professional life in Sweden
7. Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials
8. Opposite PAR2 roles in liver regeneration from autoimmune or direct damage. Solving the conflict
9. Racial and ethnic disparities in surgical care for endometriosis across the United States
10. Letter: Keeping Lawyers and Lifeguards Out of the Operating Room During Operative Hysteroscopy
11. International Consensus Statement for Recommended Terminology Describing Hysteroscopic Procedures
12. Efficacy and safety of elagolix with add-back therapy in women with uterine fibroids and coexisting adenomyosis
13. A Perspective on James Marion Sims, MD, and Antiblack Racism in Obstetrics and Gynecology
14. Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids
15. FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells
16. LINZAGOLIX MAY ADDRESS THE LONG-TERM TREATMENT NEEDS OF WOMEN WITH UTERINE FIBROIDS (UF) WHO HAVE CONTRAINDICATIONS TO HORMONAL ADD-BACK THERAPY (ABT): RESULTS FROM TWO PHASE 3 RANDOMIZED CLINICAL TRIALS
17. COVID-19 Pandemic. Impact on Hysteroscopic Procedures: A Consensus Statement from the Global Congress of Hysteroscopy Scientific Committee
18. The gut microbiome: an unexpected player in cancer immunity
19. Use of hysteroscopy in diagnosis and follow-up of acquired uterine enhanced myometrial vascularity
20. Prebiotic-Induced Anti-tumor Immunity Attenuates Tumor Growth
21. Improvement in health-related quality of life (HRQoL) in women with uterine fibroids (Uf) treated with vilaprisan (VPR): a summary of results from asteroid 1 and 2
22. Effect of fibroid location and size on efficacy of elagolix: results from phase 3 clinical trials
23. Workplace Harassment and Discrimination in Gynecology: Results of the AAGL Member Survey
24. Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study
25. Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis
26. ACR Appropriateness Criteria ® Radiologic Management of Uterine Leiomyomas
27. Treatment of mucopolysaccharidosis type II (Hunter syndrome): results from a systematic evidence review
28. PSGL-1: A New Player in the Immune Checkpoint Landscape
29. Leiomyoma therapeutic options: is it now prime time for stratified medicine?
30. Generating and evaluating evidence of the clinical utility of molecular diagnostic tests in oncology
31. PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion
32. PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion
33. An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas
34. The medical management of abnormal uterine bleeding in reproductive-aged women
35. Targeting CD44 augments the efficacy of Tregs in autoimmune diabetes
36. Peer-reviewing in an intercultural wiki environment - student interaction and reflections
37. The impact of uterine leiomyomas: a national survey of affected women
38. The Woman at the End of the Speculum
39. Can Factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcomes?: Results from a targeted evidence-based review
40. Clinical Practice Guideline for Abnormal Uterine Bleeding: Hysterectomy versus Alternative Therapy
41. Further Validation of the Uterine Fibroid Symptom and Quality-of-Life Questionnaire
42. IL-7 uniquely maintains FoxP3+ adaptive Treg cells that reverse diabetes in NOD mice via integrin-β7-dependent localization
43. Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer
44. Use of genomic profiling to assess risk for cardiovascular disease and identify individualized prevention strategies—A targeted evidence-based review
45. Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation
46. Outcomes of interest in evidence-based evaluations of genetic tests
47. CD44 Regulates Survival and Memory Development in Th1 Cells
48. Uterine fibroid embolization: a viable alternative to hysterectomy
49. Uptake of clinical genetic testing for ovarian cancer in Ontario: A population-based study
50. Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.